SenateS. 4327119th Congress

A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.

← Back to bill overviewView on Congress.gov →

Full text is not yet available for this bill. It may still be processing.

Read the full text on Congress.gov →